Video

VIDEO: Pattern recognition provides clues to rheumatologic diagnoses


 

EXPERT ANALYSIS FROM SDEF HAWAII DERMATOLOGY SEMINAR

Several patterns can provide clues to diagnoses of rheumatologic diseases, according to Daniel E. Furst, MD, professor of rheumatology, University of Washington, Seattle.

Dermatology and rheumatology share the use of pattern recognition when making a diagnosis, he said in a video interview at the Hawaii Dermatology Seminar provided by Global Academy for Medical Education/Skin Disease Education Foundation. An important pattern is the idea of polyarticular versus monoarticular disease. Rheumatoid arthritis, osteoarthritis, autoimmune diseases, and gout and crystalline diseases, he said, encompass “about 80% of the cases with polyarticular arthritis.”

Another pattern to consider is symmetry versus asymmetry. Osteoarthritis and gout will be asymmetric, while autoimmune diseases and RA will be symmetrical, Dr. Furst pointed out. Also consider areas of involvement, such as upper and lower parts of the body. “Lower tends to be more gout and more OA,” while upper-extremity involvement is more likely to be autoimmune diseases and RA, he said.

“You don’t have to be Einstein to be a rheumatologist; just remember some simple stuff,” added Dr. Furst, who also discusses the use of lab tests in the interview.

Dr. Furst is also professor emeritus, University of California, Los Angeles, and is affiliated with the University of Florence (Italy) Medical School.

He disclosed financial relationships with companies including AbbVie, Actelion, Amgen, BMS, Cytori, Genentech/Roche, Novartis, and Pfizer.

SDEF and this news organization are owned by the same parent company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Myeloablative HSCT bests IV CYC for systemic scleroderma
MDedge Dermatology
VIDEO: Statins cut mortality in ankylosing spondylitis, psoriatic arthritis
MDedge Dermatology
Low-dose IL-2 shows promise for refractory lupus
MDedge Dermatology
Mycophenolate puts lupus patients in remission faster than azathioprine
MDedge Dermatology
Prenatal exposure to hydroxychloroquine cuts risk of neonatal cutaneous lupus
MDedge Dermatology
Lupus patients may be shortchanged on lipid management
MDedge Dermatology
Medicare payments set for infliximab biosimilar Inflectra
MDedge Dermatology
Symptoms don’t worsen during pregnancy in most PsA patients
MDedge Dermatology
Bone fractures more likely to occur in psoriasis, PsA patients
MDedge Dermatology
FDA opens abbreviated approval pathway for interchangeable biosimilars
MDedge Dermatology